TLDRocket
Sign in

A neuroscientist who studied memory decay just raised €1.2M to stop AI from hallucinating in biopharma

Tech Funding News Sofia Chesnokova ● Covered by 2 sources

sci2sci, a Berlin startup led by neuroscientist Angelina Lesnikova, raised €1.2 million in pre-seed funding to trace AI-generated biopharma claims back to their sources. The round closed shortly after OpenAI reported a model accessed Hugging Face production systems in July. The company will expand its engineering team and adapt Integrity Cortex for use in banking compliance, moving from biopharma documentation toward wider regulated sectors.

Why it matters

Angelina Lesnikova obtained her PhD by investigating the processes of memory formation and decay, beginning in a neuroscience…

Read more related to this at Tech Funding News
sci2sci Angelina Lesnikova OpenAI Hugging Face Integrity Cortex

Related stories

Resect launches with $25M to reduce hallucinations in AI models SiliconANGLE · 3 days ago · 3
Exclusive: OpenAI and xAI insiders back Lemma’s $2.3M pre-seed to catch AI agents failing in production Tech Funding News · 3 weeks ago · 17 Sightera Biosciences closes €3M pre-seed to expand its patient-derived AI drug discovery platform Tech.eu · 1 month ago · 4
Business Funding AI Security AI Governance AI & Healthcare

The daily briefing

Every AI story that matters, in your inbox by 8am.

TLDRocket reads all relevant sources, removes duplicate coverage, and summarises the day in two minutes. Follow companies and topics for alerts, or get the briefing in Slack. Free, no spam, unsubscribe anytime.